Researcher
Andrea Pavesi is a Principal Investigator at A*STAR’s Institute of Molecular and Cell Biology (IMCB), working on innovative technological platforms for cancer research. His primary focus is to create organ-on-a-chip models to mimic the tumour microenvironment features and engineer the human immune system to treat cancer—enhancing immune cell populations to improve their efficacy against solid tumours. He is also a co-founding member of AIM Biotech, a Singapore-based startup integrated into the lab as a service facility. Pavesi earned his PhD degree in Biomedical and Biomechanical Engineering and completed his postdoctoral training through the Singapore-MIT Alliance (SMART).
Related Articles
Engineered brain model forges cancer breakthroughs
18 Apr 2024Researchers develop a new technology for studying how brain tumours interact with the blood-brain barrier
Tenacious T cells triumph over tumours
18 Aug 2023Researchers develop a protocol to boost the effectiveness of and reduce the risk of potential
Reprogramming T cells to attack solid tumors
17 Mar 2019A two-pronged genetic manipulation of T cells of the human immune system could lead to